CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
OPERATING ACTIVITIES
Net income including non-controlling interests	$ 17,740	$ 15,268
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:
Depreciation and amortization	4,158	3,674
Provision for doubtful accounts	2,045	2,052
Equity-based awards compensation expense	2,484	2,206
Loss (gain) on sale of fixed assets	0	(13)
Excess tax benefit from exercise of equity-based awards	0	(430)
Deferred income tax	4,170	2,130
Other	(556)	111
Changes in operating assets and liabilities:
Increase in patient accounts receivable	(2,449)	(2,880)
Decrease in accounts receivable - other	53	165
Increase in other assets	(2,443)	(13)
Increase (decrease) in accounts payable and accrued expenses	7,715	(3,958)
Increase in other liabilities	447	927
Net cash provided by operating activities	33,364	19,239
INVESTING ACTIVITIES
Purchase of fixed assets	(3,453)	(2,873)
Purchase of businesses, net of cash acquired	(12,958)	(14,467)
Acquisitions of non-controlling interests (including redeemable non-controlling interests)	(1,386)	(968)
Proceeds on sale of fixed assets, net	42	72
Net cash used in investing activities	(17,755)	(18,236)
FINANCING ACTIVITIES
Distributions to non-controlling interests (including redeemable non-controlling interests)	(5,204)	(4,906)
Cash dividends to shareholders - funded	(4,254)	(3,723)
Proceeds from revolving line of credit	93,000	51,000
Payments on revolving line of credit	(94,500)	(44,500)
Principal payments on notes payable	(533)	(608)
Tax benefit from equity-based awards	556	430
Other	1	5
Net cash used in financing activities	(10,934)	(2,302)
Net increase in cash and cash equivalents	4,675	(1,299)
Cash and cash equivalents - beginning of period	15,778	14,271
Cash and cash equivalents - end of period	20,453	12,972
Cash paid during the period for:
Income taxes	5,513	3,835
Interest	512	460
Non-cash investing and financing transactions during the period:
Purchase of business - seller financing portion	500	1,350
Acquisition of noncontrolling interest - seller financing portion	514	627
Sale of non-controlling interests	$ (148)	$ 0